Mesut Arıcı

Dr. Mesut Arıcı

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2014 in Journal of Microencapsulation
Verified
Journal Article
Closed access
PDF file
MAMesut Arıcı
Mesut Arıcı
OTOzlem Topbas
Ozlem Topbas
SKSinem Yaprak Karavana
Sinem Yaprak Karavana
GEGokhan Ertan
Gokhan Ertan
MSMerih Sariisik
Merih Sariisik
COCihat Ozturk
Cihat Ozturk
The objective of this study is to develop a new textile-based drug delivery system containing naproxen (NAP) microparticles and to evaluate the potential of the system as the carrier of NAP for topical delivery. Microparticles were prepared by spray-drying using an aqueous ethyl cellulose dispersion. The drug content and entrapment efficiency, particle size and distribution, particle morphology and in vitro drug release characteristics of microparticles were optimized for the application of microparticles onto the textile fabrics. Microparticles had spherical shape in the range of 10–15 μm and a narrow particle size distribution. NAP encapsulated in microparticles was in the amorphous or partially crystalline nature. Microparticles were tightly fixed onto the textile fabrics. In vitro drug release exhibited biphasic release profile with an initial burst followed by a very slow release. Skin permeation profiles were observed to follow near zero-order release kinetics.

9 June 2020 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
KDKubra Durkan
Kubra Durkan
ÇİÇiğdem İçhedef
Çiğdem İçhedef
AKAyfer Yurt Kılcar
Ayfer Yurt Kılcar
MAMesut Arıcı
Mesut Arıcı
EUEser Ucar
Eser Ucar
In the current study, ibuprofen (ibu) which is a non-steroidal anti-inflammatory drug (NSAID) was radiolabeled with 99mTc using two different methods: stannous chloride method (direct route) and technetium-99m tricarbonyl [99mTc(CO)3]+ route. Thus, it’s aimed to investigate the radiolabeling potential of ibu for inflammation detection and to monitor if there is any difference in in vivo distribution depending on the radiolabeling route. Quality control studies of both radiolabeled ibu were performed by radiochromatographic methods (Thin Layer Liquid Radio Chromatography and High Performance Liquid Radio Chromatography). Radiolabeling yields of 99mTc-ibu and 99mTc(CO)3-ibu were determined as 99.05 ± 0.83% and 91.79 ± 3.30% (n = 5), respectively. Experimental lipophilicities of both radiolabeled ibu were determined. The biological behaviour of both radiolabeled ibu was investigated in healthy Albino Wistar male rats by in vivo biodistribution studies. It was seen that both radiolabeled ibuprofen showed renal excretion while organ uptakes of 99mTc-ibu and 99mTc(CO)3-ibu differ against time.

1 January 2018
Verified
Book Chapter
Closed access
AYAysu Yurdasiper
Aysu Yurdasiper
MAMesut Arıcı
Mesut Arıcı
MOMine Ozyazici
Mine Ozyazici

1 January 2021 in Journal of Dr Behcet Uz Children s Hospital
Verified
Journal Article
Open access
ŞKŞükran Köse
Şükran Köse
TKTuba Tatlı Kiş
Tuba Tatlı Kiş
Gülden DinizGülden Diniz
Gülden Diniz
IAIlkay Akbulut
Ilkay Akbulut
BSBaşak Göl Serin
Başak Göl Serin
OYOsman Yılmaz
Osman Yılmaz
Objective: Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa mediated by IgE after exposure to an allergen. The most well known related comorbidity of AR is asthma. This study was planned due to the need for an animal model for studies on AR-asthma coexistence. In this study, the frequency of AR accompanying in the asthma model created in mice,and the usability of the related model in AR studies will be investigated. Methods: In our study, 6-8 week-old, 18-20 g BALB/c mice were used. Chicken egg ovalbumin (OVA Grade V, Sigma) was administered through intraperitoneal (IP) route at doses of 10 μg on days 0 and 14. Mice were exposed to aerosolized 2.5% ovalbumin solution in sterile saline for 30 minutes 3 days a week for 8 weeks, starting 7 days after the last IP administration (21st day). After exposure to OVA, mice were observed for typical signs of AR including sneezing, runny nose, and nasal itching. The final diagnosis of AR was made by histopathological examination of the rhinotracheal tissues of mice. Results: In our study, all mice exposed to ovalbumin received histopathologic diagnosis of AR. Increased number of capillaries lymphocytes, polymorphonuclear leukocytes and eosinophilsper square millimetre of rhinotracheal tissues were calculated in the murine model of AR compared to the the control group. Conclusion: This study introduced a new AR model, not cited in the literature, and induced with the longest-term ovalbumin exposure in the literature. It was concluded that this model, known as the asthma model, can also be used to induce an AR model and can be used in studies investigating coexistence of allergic rhinitis and asthma.

28 April 2017 in Current Drug Delivery
Verified
Journal Article
Closed access
MAMesut Arıcı
Mesut Arıcı
SKSalih Kavukcu
Salih Kavukcu
STSakine Tuncay Tanriverdi
Sakine Tuncay Tanriverdi
AAAylin Arici
Aylin Arici
SGSedef Gidener
Sedef Gidener
OOOzgen Ozer
Ozgen Ozer
Objectives: Nitrofurantoin is widely used in the prophylaxis of urinary-tract infections. The aim of this study was to develop and characterize innovative transdermal formulations of nitrofurantoin, to increase the patient compliance and decrease the adverse effects such as nausea and vomiting which limit the drug use in long-term. Methods: Nitrofurantoin loaded microemulsion, gel (hydrogel, lipogel and DMSO gel) and film formulations were prepared and characterized via several parameters. Ex-vivo drug permeation studies were performed to determine the amount of drug permeated through the rat skin. In in-vivo studies, in order to detect nitrofurantoin in urine, the selected formulations were applied to male Wistar rats transdermally. Also, skin irritation tests (transepidermal water loss and erythema) were performed. Results: All nitrofurantoin loaded formulations were prepared successfully and were stable at +4oC for 3 months. 13%, 16%, 32.5%, 36.5% and 39% of drug permeated through the rat skin in the 168th hour for hydrogel, lipogel, film, microemulsion and DMSO gel, respectively. Only with film and DMSO gel formulations, nitrofurantoin was detected in urine. Transepidermal water loss was increased compared to basal level in film type formulations (p0.05). Conclusion: There is no approved transdermal formulation of nitrofurantion on the market. Therefore, the prepared film formulations could be an alternative due to their high penetration through the rat skin, the presence of nitrofurantoin in urine and because they cause no irritation on the skin.